Impact of UGT1A1 Gilbert Variant on Discontinuation of Ritonavir-Boosted Atazanavir in AIDS Clinical Trials Group Study A5202

The UGT1A1*28 variant has been associated with hyperbilirubinemia and atazanavir discontinuation. Protocol A5202 randomly assigned human immunodeficiency virus type 1 (HIV-1)–infected patients to receive atazanavir/ritonavir (atazanavir/r) or efavirenz, with tenofovir/emtricitabine or abacavir/lamiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ribaudo, Heather J., Daar, Eric S., Tierney, Camlin, Morse, Gene D., Mollan, Katie, Sax, Paul E., Fischl, Margaret A., Collier, Ann C., Haas, David W.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2013
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537445/
https://ncbi.nlm.nih.gov/pubmed/23148286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados